{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:52:39Z","timestamp":1792515159988,"version":"4.5.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T00:00:00Z","timestamp":1570492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2019.01112","type":"journal-article","created":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T04:11:52Z","timestamp":1570507912000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Impacts of Clinical Pharmacist Intervention on the Secondary Prevention of Coronary Heart Disease: A Randomized Controlled Clinical Study"],"prefix":"10.3389","volume":"10","author":[{"given":"Huimin","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunbin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,10,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1161\/CIRCOUTCOMES.109.919415","article-title":"Optimal medical therapy for non-ST-segment-elevation acute coronary syndromes: exploring why physicians do not prescribe evidence-based treatment and why patients discontinue medications after discharge","volume":"3","author":"Bagnall","year":"2010","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"B2","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1001\/archinte.167.6.586","article-title":"An intervention to improve secondary prevention of coronary heart disease","volume":"167","author":"Bailey","year":"2007","journal-title":"Arch. Intern. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1186\/1472-6963-13-461","article-title":"Pharmacist care and the management of coronary heart disease: a systematic review of randomized controlled trials","volume":"13","author":"Cai","year":"2013","journal-title":"BMC Health Serv. Res."},{"key":"B4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2012.01.019","article-title":"Patient-focused intervention to improve long-term adherence to evidence-based medications: a randomized trial","volume-title":"Am. Heart J.","author":"Calvert","year":"2012"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.5867\/medwave.2017.05.6989","article-title":"Medical compliance to evidence-based clinical guidelines on secondary prevention of coronary heart disease in a hospital from Lima, Peru: a retrospective study","volume":"17","author":"Castaneda-Amado","year":"2017","journal-title":"Medwave"},{"key":"B6","first-page":"172","article-title":"Randomised controlled trials (RCTs)\u2014sample size: the magic number","volume":"44","author":"Chan","year":"2003","journal-title":"Singapore Med. J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.jfma.2013.08.001","article-title":"Predictors of 1-year outcomes in the Taiwan Acute Coronary Syndrome Full Spectrum Registry","volume":"113","author":"Chiang","year":"2014","journal-title":"J. Formos. Med. Assoc."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1093\/eurheartj\/eht295","article-title":"Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences","volume":"34","author":"Chowdhury","year":"2013","journal-title":"Eur. Heart. J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/fampra\/cml075","article-title":"The MEDMAN study: a randomized controlled trial of community pharmacy-led medicines management for patients with coronary heart disease","volume":"24","year":"2007","journal-title":"Fam. Pract."},{"key":"B10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.sapharm.2018.04.003","article-title":"A review of interventions >\/=6 months by pharmacists on adherence to medicines in cardiovascular disease: characteristics of what works and what doesn\u2019t","volume":"15","author":"Doggrell","year":"2019","journal-title":"Res. Social Adm. Pharm."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1177\/2047487315607041","article-title":"Impacts of intensive follow-up on the long-term prognosis of percutaneous coronary intervention in acute coronary syndrome patients\u2014a single center prospective randomized controlled study in a Chinese population","volume":"23","author":"Du","year":"2016","journal-title":"Eur. J. Prev. Cardiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1592\/phco.20.5.410.35048","article-title":"Impact of pharmacy counseling on compliance and effectiveness of combination lipid-lowering therapy in patients undergoing coronary artery revascularization: a randomized, controlled trial","volume":"20","author":"Faulkner","year":"2000","journal-title":"Pharmacotherapy"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1016\/S014-6736(18)32335-3","article-title":"Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1001\/archinte.167.16.1798","article-title":"Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the heart and soul study","volume":"167","author":"Gehi","year":"2007","journal-title":"Arch. Intern. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","article-title":"ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)","volume":"32","author":"Hamm","year":"2011","journal-title":"Eur. Heart J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1001\/jamainternmed.2013.12944","article-title":"Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial","volume":"174","author":"Ho","year":"2014","journal-title":"JAMA Intern. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1001\/archinte.166.17.1842","article-title":"Impact of medication therapy discontinuation on mortality after myocardial infarction","volume":"166","author":"Ho","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1136\/heartjnl-2013-303989","article-title":"Effect of a nurse-coordinated prevention programme on cardiovascular risk after an acute coronary syndrome: main results of the RESPONSE randomised trial","volume":"99","author":"Jorstad","year":"2013","journal-title":"Heart"},{"key":"B19","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1001\/jamacardio.2019.0295","article-title":"Burden of cardiovascular diseases in China, 1990\u20132016: findings from the 2016 Global Burden of Disease Study","volume":"4","author":"Liu","year":"2019","journal-title":"JAMA Cardiol."},{"key":"B20","first-page":"307","article-title":"Cost of care for new-onset acute coronary syndrome patients who undergo coronary revascularization","volume":"17","author":"Mccollam","year":"2005","journal-title":"J. Invasive Cardiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1185\/030079908X261096","article-title":"One-year costs of ischemic heart disease among patients with acute coronary syndromes: findings from a multi-employer claims database","volume":"24","author":"Menzin","year":"2008","journal-title":"Curr. Med. Res. Opin."},{"key":"B22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1161\/CIRCULATIONAHA.105.505636","article-title":"Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease","volume":"113","author":"Newby","year":"2006","journal-title":"Circulation"},{"key":"B23","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3389\/fphar.2018.00656","article-title":"Pharmacist-led intervention to enhance medication adherence in patients with acute coronary syndrome in Vietnam: a randomized controlled trial","volume":"9","author":"Nguyen","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2017-000687","article-title":"Effectiveness of pharmacist\u2019s intervention in the management of cardiovascular diseases","volume":"5","author":"Omboni","year":"2018","journal-title":"Open. Heart"},{"key":"B25","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1365-2125.2005.02387.x","article-title":"Pharmaceutical care of patients with heart failure","volume":"60","author":"Sadik","year":"2005","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1001\/archinternmed.2011.399","article-title":"Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials","volume":"171","author":"Santschi","year":"2011","journal-title":"Arch. Intern. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.ahj.2015.08.014","article-title":"Cluster randomized controlled trial of Delayed Educational Reminders for Long-term Medication Adherence in ST-Elevation Myocardial Infarction (DERLA-STEMI)","volume":"170","author":"Schwalm","year":"2015","journal-title":"Am. Heart J."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1161\/CIR.0b013e318235eb4d","article-title":"AHA\/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation","volume":"124","author":"Smith","year":"2011","journal-title":"Circulation"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/S0140-6736(99)03428-5","article-title":"Effects of a multidisciplinary, home-based intervention on unplanned readmissions and survival among patients with chronic congestive heart failure: a randomised controlled study","volume":"354","author":"Stewart","year":"1999","journal-title":"Lancet"},{"key":"B30","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1592\/phco.25.3.360.61601","article-title":"Achieving cholesterol target in a managed care organization (ACTION) trial","volume":"25","author":"Straka","year":"2005","journal-title":"Pharmacotherapy"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1016\/S0140-6736(08)60868-5","article-title":"Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial","volume":"371","author":"Wood","year":"2008","journal-title":"Lancet"},{"key":"B32","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s11655-013-1663-8","article-title":"Use of evidence-based pharmacotherapy for secondary prevention of coronary heart disease: a Chinese medicine hospital versus a general hospital","volume":"20","author":"Xu","year":"2014","journal-title":"Chin. J. Integr. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.01112\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T04:11:55Z","timestamp":1570507915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.01112\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,8]]},"references-count":32,"alternative-id":["10.3389\/fphar.2019.01112"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2019.01112","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,8]]},"article-number":"1112"}}